Bryn Pharma, a privately held pharmaceutical company focused on creating a new treatment for anaphylaxis – a life-threatening allergic reaction – not only has a new CEO and COO but also $15 million in cash as the company seeks FDA approval for its unique nasal spray.
Source: WRAL News
Fighting anaphylaxis without needles: Raleigh pharma startup raises $15M
Published in Marshallberg
Be First to Comment